Evidence map›Paper›PMID 41419250›Full record

ArticleBMJ global health2025

Global effects of increased taxation of tobacco, alcohol and sugar-sweetened beverages on tax receipts: a modelling analysis.

Amit Summan, Peter Baker, Katherine Klemperer, Ramanan Laxminarayan

Abstract read
In one paragraph

Article in BMJ global health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Amit SummanOne Health Trust, Washington, District of Columbia, USA summan@onehealthtrust.org.ORCID 0000-0001-5762-9174
Peter BakerCenter for Global Development, London, UK.
Katherine KlempererCenter for Global Development, London, UK.
Ramanan LaxminarayanOne Health Trust, Bengaluru, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe taxation of harmful commodities-including tobacco, alcohol and sugar-sweetened beverages (SSBs)-can reduce avertable health burdens while generating tax revenue to fund key government programmes. These tools are particularly useful in the current environment of constrained global fiscal space but remain underused.

methodsWe simulated the economic effects of taxing cigarettes, alcohol and SSBs over a 5-year period employing mathematical models informed by global economic and consumption data. Historical trends were used to project baseline consumption trajectories for each commodity. For countries with missing data, price, consumption and tax information were imputed using regional and income group averages, enabling global coverage. Tax-induced price increases of 20% and 50% were simulated.

resultsTaxes that raise retail prices by 20% would generate US$388.73 billion in additional global tax revenue annually, comprising US$104.20 (95% UI: US$92.70-US$115.48) billion from tobacco, US$202.67 (95% UI: US$191.68-US$213.69) billion from alcohol, and US$81.86 (95% UI: US$68.36-US$94.93) billion from SSBs. At 50%, the total additional revenue would be US$684.75 billion annually. As a proportion of health spending, lower-income countries generate more tax revenue than higher-income countries.

conclusionExcise tax increases on tobacco, alcohol and SSBs can raise substantial government revenues, which could enable increased public health and social spending. By providing short-term revenue projections, this study offers timely insights to inform near-term fiscal policy decisions, particularly in low- and middle-income countries facing fiscal constraints. Future research should explore the taxation of related goods, including ultraprocessed foods and e-cigarettes.

Indexed as

Alcoholic BeveragesGlobal HealthSugar-Sweetened BeveragesTaxesTobacco ProductsCommerceHumansModels, TheoreticalControl strategiesHealth economicsHealth policyTobacco

Identifiers

PMID41419250
PMCPMC12716585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.